Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers

Journal of Cardiovascular Pharmacology

Volumn 37, Issue 6, 2001, Pages 692-696

  Berlowitz, Michael S ^a   Latif, Farhana ^a   Hankins, Shelley R ^a   Ennezat, Pierre Vladimir ^a   Moskowitz, Robert ^a   Tandon, Suman ^a   Colombo, Paolo C ^a   Le Jemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensin II receptor antagonist; Candesartan; Losartan

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CANDESARTAN; LOSARTAN; PLACEBO;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANTIHYPERTENSIVE AGENTS; BENZIMIDAZOLES; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LOSARTAN; MALE; MIDDLE AGED; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; TETRAZOLES; VASOCONSTRICTOR AGENTS;

EID: 0035007236     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200106000-00006     Document Type: Article

References (5)

1. Carr AA, Prisant ML. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. J Clin Pharmacol 1996;36:3-12.
2. Gradman AH, Arcuri KE, Goldberg AI, et al. A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension. Hypertension 1995;25:1345-50.
3. Roca-Cusachs A, Oigman W, Lepe L, et al. A randomized, double-blind comparison of the antihypertensive efficacy and safety of once-daily losartan compared with twice-daily captopril in mild to moderate essential hypertension. Acta Cardiol 1997;52:495-506.
4. Ikeda LS, Harm SC, Arcuri KE, et al. Comparative antihypertensive effects of losartan 50 mg and losartan 50 mg titrated to 100 mg in patients with essential hypertension. Blood Press 1997;6:35-43.
5. Timmermans PB, Benfield P, Chiu AT, et al. Angiotensin II receptors and functional correlates. Am J Hypertens 1992;5:221S-35S.